Medovent Elixir

Ambroxol Hydrochloride, the active ingredient in Medovent Elixir, is a mucolytic presented as an oral liquid for oral use. It reduces the viscosity of respiratory secretions, aiding cough with thick sputum in adults and children, and is used for bronchitis and other respiratory tract infections.

GNH USA supplies Medovent Elixir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring consistent quality and regulatory compliance, and timely delivery to meet patient needs through a robust supply chain network.

Ambroxol Hydrochloride is a mucolytic that facilitates mucus clearance in the respiratory tract.

- Cough with thick sputum: Improves clearance of thick mucus, reducing cough frequency. - Bronchitis: Enhances expectoration, helping relieve airway obstruction. - Respiratory tract infections: Assists in thinning secretions to support normal mucociliary function.

Adverse reactions may occur with any mucolytic therapy.

Common Side Effects: - Altered taste sensation: transient metallic or bitter taste. - Nausea: mild to moderate discomfort in the stomach. - Vomiting: occasional emesis after dosing. - Diarrhea: loose stools without blood. - Abdominal discomfort: cramping or mild pain. - Headache: dull or throbbing pain. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Allergic reaction: urticaria, swelling, or anaphylaxis. - Angioedema: rapid swelling of lips, tongue, or face. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: abnormal liver function tests. - Pancreatitis: acute abdominal pain with elevated enzymes. - Eosinophilia: increased eosinophil count in blood.

When prescribing Ambroxol Hydrochloride, consider the following safety measures.

- Assess renal function: adjust use in severe renal impairment. - Monitor hepatic status: avoid in patients with active liver disease. - Caution in asthma: ensure underlying bronchospasm is controlled. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Use with caution in pregnancy and lactation: weigh benefits against potential risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Ambroxol Hydrochloride has a low interaction profile, but certain combinations require attention.

Major Interactions (Avoid): - Concurrent use with other mucolytics: may increase gastrointestinal irritation. - Combination with strong antitussives that suppress cough reflex: may reduce therapeutic benefit.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): possible increase in ambroxol plasma levels. - Bronchodilators (e.g., salbutamol): additive effect on airway smooth‑muscle tone. - Antihistamines: may enhance sedation or drowsiness. - Anticoagulants: monitor for altered bleeding risk, although evidence is limited.